首页 > 市场调查报告书 > 医疗设备

眼科设备

仿生眼市场规模、份额和成长分析（按类型、技术、义眼系统、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902547

仿生眼市场规模、份额和成长分析（按类型、技术、义眼系统、最终用户和地区划分）－2026-2033年产业预测

Bionic Eye Market Size, Share, and Growth Analysis, By Type (External Eye, Implanted Eye), By Technology (Electronic, Mechanical), By Prosthesis System, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，仿生眼市场规模将达到 3.4033 亿美元，到 2025 年将成长至 3.8417 亿美元，到 2033 年将成长至 10.1265 亿美元，在预测期（2026-2033 年）内，复合年增长率为 12.复合年增长率。

受视网膜疾病发生率上升和人口老化的影响，仿生眼市场正经历强劲成长。这些因素催生了对能够恢復视力的先进解决方案的巨大需求。仿生眼技术的创新，包括可植入设备和与功能性视网膜细胞相互作用的外部影像处理单元，正在提升视觉能力。持续的研究旨在提高解析度和整体性能，从而改善患者的治疗效果。然而，该市场也面临许多挑战，例如植入和手术高成本，限制了许多患者（尤其是在发展中地区）的接受度。此外，仿生眼的长期安全性和有效性正受到密切关注，而监管障碍和各地不同的报销政策也进一步阻碍了市场的普及和成长。

仿生眼市场驱动因素

视网膜色素变性和老龄化黄斑部病变等视网膜疾病的日益增加是推动仿生眼市场成长的关键因素。随着越来越多的人因这些视网膜疾病而遭受严重的视力障碍甚至失明，人们对旨在恢復视力的创新仿生眼技术的需求也日益增长。这种对有效解决方案的需求推动了仿生眼研发领域的关注和投资，以满足那些希望恢復视力并提高生活品质的人们的需求。随着人们对这些疾病的认识不断提高，视力恢復设备的进步潜力也随之增强。

限制仿生眼市场的因素

仿生眼市场面临许多挑战，其中植入设备的高昂成本以及相关的手术费用尤其突出。这些成本构成了巨大的准入障碍，尤其是在医疗基础设施落后、保险覆盖不足的地区。设备带来的经济负担以及保险覆盖的困难会阻碍仿生眼技术的广泛应用。因此，价格承受能力问题和有限的保险覆盖范围成为市场成长的障碍，影响着人们从仿生眼技术带来的视力恢復解决方案中获益的能力。

仿生眼市场趋势

仿生眼市场正呈现小型化和植入式设计的显着趋势，这提高了患者的舒适度和手术可行性。这些进步使得更小巧、更隐密、更易于安装的设备得以研发，从而改善了患者的整体体验。此外，具备无线供电和资料传输功能的创新植入式仿生眼正日益受到关注，有助于与现有医疗生态系统无缝整合。这种向小型化解决方案的转变不仅推动了视力恢復技术的进步，也凸显了医疗设备业日益重视以患者为中心的设计理念，有望扩大市场覆盖范围并改善临床疗效。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Second Sight Medical Products, Inc.（USA）
Pixium Vision（France）
Monash Vision Group（Australia）
Nano Retina Ltd.（Israel）
Optobionics Corporation（Japan）
Nidek Co., Ltd.（Japan）
Bionic Vision Technologies（Australia）
iBionics（USA）
Vivani Medical Inc.（USA）
MetaModal LLC（USA）
Biomedical Technologies SL（Spain）

结论与建议

简介目录

Product Code: SQMIG35H2113

Bionic Eye Market size was valued at USD 340.33 Million in 2024 and is poised to grow from USD 384.17 Million in 2025 to USD 1012.65 Million by 2033, growing at a CAGR of 12.88% during the forecast period (2026-2033).

The bionic eye market is witnessing robust growth, driven by rising retinal disease prevalence and an aging population. These factors generate substantial demand for advanced solutions capable of restoring vision. Innovations in bionic eye technology, including implantable devices that interact with functional retinal cells and external image processing units, are leading to enhanced visual capabilities. Ongoing research aims to improve resolution and overall performance, contributing to better patient outcomes. However, the market faces challenges such as high costs associated with implants and surgical procedures, limiting access for many, especially in developing regions. Additionally, the long-term safety and efficacy of bionic eyes are under scrutiny, and regulatory hurdles combined with varying reimbursement policies further complicate market adoption and growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bionic Eye market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bionic Eye Market Segments Analysis

Global Bionic Eye Market is segmented by type, technology, end users, prosthesis system and region. Based on type, the market is segmented into external eye and implanted eye. Based on technology, the market is segmented into electronic and mechanical. Based on prosthesis system, the market is segmented into Argus II, Alpha IMS, Alpha AMS, IRIS II, and Others. Based on end users, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bionic Eye Market

The growing prevalence of retinal diseases, including conditions like retinitis pigmentosa and age-related macular degeneration, plays a crucial role in driving the bionic eye market. With an increasing number of people experiencing severe vision impairment or blindness as a result of these retinal disorders, there is an escalating demand for innovative bionic eye technologies aimed at restoring vision. This need for effective solutions enhances interest and investment in bionic eye developments, catering to those seeking to regain their sight and improve their quality of life. As awareness of these conditions rises, so too does the potential for advancements in vision restoration devices.

Restraints in the Bionic Eye Market

The bionic eye market faces significant challenges due to the high costs associated with implants and the surgical procedures required for their installation. These expenses create substantial barriers to accessibility, particularly in areas where healthcare infrastructure is lacking or reimbursement options are inadequate. The financial burden of these devices and the difficulties in obtaining coverage can impede the widespread adoption of bionic eye technology. As a result, affordability issues and limited reimbursement opportunities serve as obstacles to market growth, impacting the potential for individuals to benefit from advancements in vision restoration solutions offered by bionic eye innovations.

Market Trends of the Bionic Eye Market

The bionic eye market is experiencing a notable trend toward miniaturisation and implantable designs, enhancing both patient comfort and surgical feasibility. These advancements enable the development of smaller, more discreet devices that are easier to install, thereby improving the overall patient experience. Additionally, innovative implantable bionic eyes equipped with wireless power and data transmission capabilities are gaining prominence, facilitating seamless integration with existing healthcare ecosystems. This shift towards compact solutions not only supports advancements in vision restoration technologies but also emphasizes the growing focus on patient-centric designs in the medical device industry, potentially expanding market reach and improving clinical outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Bionic Eye Market Size by Type & CAGR (2026-2033)

Market Overview
External Eye
Implanted Eye

Global Bionic Eye Market Size by Prosthesis System & CAGR (2026-2033)

Market Overview
Argus II
Alpha IMS
Alpha AMS
IRIS II
Others

Global Bionic Eye Market Size by Technology & CAGR (2026-2033)

Market Overview
Electronic
Mechanical

Global Bionic Eye Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals
Ophthalmic Clinics
Others

Global Bionic Eye Market Size & CAGR (2026-2033)

North America (Type, Prosthesis System, Technology, End Users)
- US
- Canada
Europe (Type, Prosthesis System, Technology, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Prosthesis System, Technology, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Prosthesis System, Technology, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Prosthesis System, Technology, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Second Sight Medical Products, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pixium Vision (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monash Vision Group (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nano Retina Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optobionics Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidek Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionic Vision Technologies (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iBionics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivani Medical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MetaModal LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomedical Technologies S.L. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments